drugset / Trial / NCT01011205
Phase 3b Study to Evaluate Advagraf in Combination With Mycophenolate Mofetil and Basiliximab in Liver Transplantation
RandomizedParallel-groupOpen-labelTreatment
Summary
Comparison of 3 dosing regimens of Advagraf to determine if there is a dosing regimen which may have the potential to cause fewer kidney problems.
Timeline
- Start
- 2009-09-30
- Primary completion
- 2013-01-04
- Completion
- 2013-01-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Basiliximab | Monoclonal antibody | — | Intravenous |
| Subject | Tacrolimus | Small molecule | — | — |
| Background | Mycophenolate Mofetil | Small molecule | — | — |
Indications
No indication recorded.